Abstract
The treatment with antiepileptic drugs (AEDs), in particular conventional drugs, induces an increased risk of fractures in women and in epileptic patients in treatment with AEDs for more than 12 years. A supplementation with calcium and vitamin D is suggested in patients chronically treated with some AEDs and there are recommendations to do so. The lack of significant conclusive evidence about the effects of conventional and newer AEDs on bone metabolism needs for more clinical studies in order to perform an appropriate use of calcium and vitamin D supplementation in young and ederly epileptic patients.
Keywords: AEDs, bone metabolism, calcium, vitamin D, women.
Current Clinical Pharmacology
Title:Conventional and New Antiepileptic Drugs on Vitamin D and Bone Health: What We Know to Date?
Volume: 11 Issue: 1
Author(s): Antonio Siniscalchi, Giovambattista De Sarro, Andzelika Michniewicz and Luca Gallelli
Affiliation:
Keywords: AEDs, bone metabolism, calcium, vitamin D, women.
Abstract: The treatment with antiepileptic drugs (AEDs), in particular conventional drugs, induces an increased risk of fractures in women and in epileptic patients in treatment with AEDs for more than 12 years. A supplementation with calcium and vitamin D is suggested in patients chronically treated with some AEDs and there are recommendations to do so. The lack of significant conclusive evidence about the effects of conventional and newer AEDs on bone metabolism needs for more clinical studies in order to perform an appropriate use of calcium and vitamin D supplementation in young and ederly epileptic patients.
Export Options
About this article
Cite this article as:
Siniscalchi Antonio, Sarro De Giovambattista, Michniewicz Andzelika and Gallelli Luca, Conventional and New Antiepileptic Drugs on Vitamin D and Bone Health: What We Know to Date?, Current Clinical Pharmacology 2016; 11 (1) . https://dx.doi.org/10.2174/157488471101160204121835
DOI https://dx.doi.org/10.2174/157488471101160204121835 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation
Current Drug Metabolism Physiology and Pathophysiology of Na+/H+ Exchange Isoform 1 in the Central Nervous System
Current Neurovascular Research Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario
Current Topics in Medicinal Chemistry Rationale Design, Synthesis, and Pharmacological Evaluation of Isatin Analogues as Antiseizure Agents
Letters in Drug Design & Discovery Outcome of Newborns with Neonatal Seizures: Risk Factors and Predictors
Current Pediatric Reviews Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents
Medicinal Chemistry Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Pathogenesis of Alcohol-Induced Osteoporosis and its Treatment: A Review
Current Drug Targets Glutamate as a Modulator of Embryonic and Adult Neurogenesis
Current Topics in Medicinal Chemistry Pharmacokinetic Studies in Infants Using Minimal-Risk Study Designs
Current Clinical Pharmacology Preparation and Characterization of Rivastigmine Loaded Human Serum Albumin (HSA) Nanoparticles
Current Drug Delivery ABC Pumps and Their Role in Active Drug Transport
Current Topics in Medicinal Chemistry Angiogenic and Vascular Modulation by Extracellular Matrix Cleavage Products
Current Pharmaceutical Design Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
Central Nervous System Agents in Medicinal Chemistry The New Antiepileptic Drugs Pharmacological and Clinical Aspects
Current Pharmaceutical Design Reversal of Neuropsychiatric Comorbidities in an Animal Model of Temporal Lobe Epilepsy Following Systemic Administration of Dental Pulp Stem Cells and Bone Marrow Mesenchymal Stem Cells
Current Gene Therapy Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease
Current Pharmaceutical Design